:

Homeland Security

Emergent BioSolutions, PharmAthene Respond to Anthrax RFP

DDN

Wednesday, August 6th, 2008

SHARE:

Emergent BioSolutions, Inc. [EBS], and PharmAthene, Inc. [PIP], have each submitted proposals to the Department of Health and Human Services (HHS) Request for Proposals issued earlier this year for a next-generation anthrax vaccine. Emergent BioSolutions' Recombinant Protective Antigen (rPA) vaccine is a reformulated and more stable form of the rPA 102 vaccine originally developed at the U.S. Army Medical Research Institute of Infectious Diseases. rPA 102 has completed one Phase II clinical trial. PharmAthene's rPA candidate is SparVax, which has…

Congress

House Republicans Block Measure To Impeach Hegseth

House Republicans on Tuesday evening voted to block an attempt to impeach Defense Secretary Pete Hegseth. In a 211-204 vote, the House moved to refer Rep. Thomas Massie’s (R-Ky.) articles […]

Congress

Top House Defense Appropriator Calvert Officially Wins Reelection Bid

Rep. Ken Calvert (R-Calif.), House Republicans’ top defense appropriator, has officially won his reelection bid. Calvert was running for a redistricted seat against fellow House Republican Rep. Young Kim (R-Calif.), […]

Congress

No Path To Defense Reconciliation, Including GOP’s $350 Billion, Coons Says

Top Senate Democrats threw cold water on any GOP plans for a $350 billion fiscal 2027 reconciliation bill, or any defense reconciliation bill, before a new Congress is sworn in […]

Congress

Industry Groups ‘Urge’ Congress To Block Stock Buyback Restriction From Final FY ‘27 NDAA

More than three dozen industry associations on Monday called on congressional defense committee leaders to scrap a provision in the final version of the next National Defense Authorization Act that […]